Big Rock Partners: Big Rock Partners Acquisition : Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press Briefing by White House COVID-19 Response Team

(marketscreener.com) RADNOR, Pa., April 26, 2021 /PRNewswire/ -- Dosing of the first patient in a phase 3 clinical trial of ZYESAMI was announced by the National Institutes of Health last week. The trial, designated as ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 , will study ZYESAMI to treat severely ill COVID-19 patients. The study...https://www.marketscreener.com/quote/stock/BIG-ROCK-PARTNERS-ACQUISI-38908842/news/Big-Rock-Partners-Acquisition-nbsp-Dr-Anthony-Fauci-Confirms-ZYESAMI-Phase-3-Trial-with-Remdesivi-33069959/?utm_medium=RSS&utm_content=20210426